High Quality Evidence of Guangzhou Lupus Nephritis Cohort (HOPE Cohort)

NCT06682507 · tracked via the Priya Life Science China tracker

Sponsor

First Affiliated Hospital, Sun Yat-Sen University

Phase

Observational

Started

1996-01-01

Last updated

2024-11-12

Condition(s) studied

Lupus Nephritis (LN)

Investigational drug(s) / intervention(s)

No Intervention: Observational Cohort

No Intervention: Observational Cohort: No Intervention: Observational Cohort

Study summary

The goal of this observational study is to learn about the long-term renal and patient's survival of lupus nephritis (LN) patients in China. The main question it aims to answer is:

Does the renal and patient's survival improved in the long term period? Participants who had renal biopsy proven lupus nephritis in one hospital will be followed up.

Eligibility

Sex

ALL

Min age

14 Years

Max age

—

Healthy volunteers

Inclusion Criteria: Patients who had biopsy proven lupus nephritis in The First Affiliated Hospital of Sun Yat-sen University Exclusion Criteria: * less than 14 years old * refused to give written consent

Primary outcome measure(s)

Rate of patients with end stage renal disease — From data of enrollment until the data of first documented end stage renal disease, assessed up to 50 years
End stage renal disease

Trial sites (1)

Facility	City	Region	Status
The First Affiliated Hospital of Sun Yat-sen University	Guangzhou	Guangdong	Recruiting

More First Affiliated Hospital, Sun Yat-Sen University trials in China

Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy Recruiting

Effectiveness of a Lifestyle Intervention for Pregnant Women With Abnormal Glucose Metabolism in Early Pregnancy: EAGM Trial Recruiting

Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis Recruiting

Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: cfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection Active, not recruiting

Efficacy of the Ranger Drug-Coated Balloon in Treating BTK Lesions in Patients With CLTI Starting soon

Other trials for the same condition

A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases Recruiting

Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN Recruiting

An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis Recruiting

Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial) Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06682507 on ClinicalTrials.gov ↗ ← All trials in China